General Practitioners' and Hospital Physicians' Preference for Morphine or Oxycodone as First-Time Choice for a Strong Opioid: A National Register-Based Study

Basic and Clinical Pharmacology and Toxicology

Volumn 112, Issue 2, 2013, Pages 110-115

  Poulsen, Karen K ^a   Andersen, Stig E ^b   Moreno, Søren I ^c   Glintborg, Dorte ^c   Thirstrup, Steffen ^d   Aagaard, Lise ^e  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b BISPEBJERG HOSPITAL   (Denmark)

^c Institute for Rational Pharmacotherapy   (Denmark)

^d Danish Health and Medicines Authority   (Denmark)

^e UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

MORPHINE; OXYCODONE;

ADULT; ARTICLE; CONTROLLED STUDY; DENMARK; DRUG PREFERENCE; FEMALE; GENERAL PRACTITIONER; HOSPITAL PHYSICIAN; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT CARE; PRESCRIPTION; PRIORITY JOURNAL;

AMBULATORY CARE; ANALGESICS, OPIOID; ATTITUDE OF HEALTH PERSONNEL; DENMARK; GENERAL PRACTITIONERS; HUMANS; MORPHINE; OUTPATIENTS; OXYCODONE; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS; REGISTRIES; RETROSPECTIVE STUDIES;

EID: 84872141294     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2012.00927.x     Document Type: Article

References (41)

1. Mucci-LoRusso P, Berman BS, Silberstein PT, Citron ML, Bressler L, Weinstein SM et al. Controlled-release oxycodone compared with controlled-release morphine in the treatment of cancer pain: a randomized, double-blind, parallel-group study. Eur J Pain 1998; 2:239-49.
2. Bruera E, Belzile M, Pituskin E, Fainsinger R, Darke A, Harzanyi Z et al. Randomized, double-blind, cross-over trial comparing safety and efficacy of oral controlled-release oxycodone with controlled-release morphine in patients with cancer pain. J Clin Oncol 1998;16:3222-9.
3. Heiskanen T, Kalso E. Controlled-release oxycodone and morphine in cancer related pain. Pain 1997;73:37-45.
4. Kalso E, Vainio A. Morphine and oxycodone hydrochloride in the management of cancer pain. Clin Pharmacol Ther 1990;47:639-46.
5. Kalso E, Pöyhiä R, Onnela P, Linko K, Tigersted I, Tammisto T. Intravenous morphine and oxycodone for pain after abdominal surgery. Acta Anaesthesiol Scand 1991;35:642-6.
6. Silvasti M, Rosenberg P, Seppälä T, Svartling N, Pitkänen M. Comparison of analgesic efficacy and oxycodone and morphine in postoperative intravenous patient-controlled analgesia. Acta Anaesthesiol Scand 1998;42:576-80.
7. Lenz H, Sandvik L, Qvigstad E, Bjerkelund CE, Raeder J. A comparison of intravenous oxycodone and intravenous morphine in patient-controlled postoperative analgesia after laparoscopic hysterectomy. Anesth Analg 2009;109:1279-83.
8. National Comprehensive Cancer Network (NCCN) guidelines. http://www.nccn.org/. (last accessed on 11 July 2012).
9. Staahl C, Dimcevski G, Andersen SD, Thorsgaard N, Christrup LL, Arendt-Nielsen L et al. Differential effect of opioids in patients with chronic pancreatitis: an experimental pain study. Scand J Gastroenterol 2007;42:383-90.
10. Staahl C, Christrup LL, Andersen SD, Arendt-Nielsen L, Drewes AM. A comparative study of oxycodone and morphine in a multi-modal, tissue-differentiated experimental pain model. Pain 2006; 123:28-36.
11. Cicero TJ, Dart RC, Inciardi JA, Woody GE, Schnoll S, Munoz A. The development of a comprehensive risk-management program for prescription opioid analgesics: researched abuse, diversion and addiction-related surveillance (RADARS). Pain Med 2007;8:157-70.
12. Cicero TJ, Ellis MS, Paradis A, Ortbal Z. Determinants of fentanyl and other potent "my" opioid agonist misuse in opioid-dependent individuals. Pharmacoepidemiol Drug Saf 2010; 19:1057-63.
13. Katz N, Fernandez K, Chang A, Benoit C, Butler SF. Internet-based survey of nonmedical prescription opioid use in the United States. Clin J Pain 2008;24:528-35.
14. Dawis WR, Johnson BD. Prescription opioid use, misuse, and diversion among street drug users in New York City. Drug Alcohol Depend 2008;92:267-76.
15. Comer SD, Sullivan MA, Whittington RA, Vosburg SK, Kowalczyk WJ. Abuse liability of prescription opioids compared to heroin in morphine-maintained heroin abusers. Neuropsychopharmacology 2008;33:1179-91.
16. Zacny JP, Gutierrez S. Characterizing the subjective, psychomotor, and psychological effects of oral oxycodone in non-drug-abusing volunteers. Psychopharmacology 2003;170:242-54.
17. Zacny JP, Lichtor SA. Within-subject comparison of the psychopharmacological profiles of oral oxycodone and oral morphine in non-drug-abusing volunteers. Psychopharmacol (Berl) 2008;196:105-16.
18. Walsh SL, Nuzzo PA, Lofwall MR, Holtman JR. The relative abuse liability of oral oxycodone, hydrocodone and hydromorphone assessed in prescription opioid abusers. Drug Alcohol Depend 2008;98:191-202.
19. Bekkering GE, Soares-Weiser K, Reid K, Kessels AG, Dahan A, Treede RD et al. Can morphine still be considered to be the standard for treating chronic pain? A systematic review including pair-wise and network meta-analyses. Curr Med Res Opin 2011;27:1477-91.
20. Danish Institute for Rational Pharmacotherapy. The National Recommendation List. http://irf.dk/rekommandationsliste/bagrundsnotater/nervesystemet_analgetika_og psykofarmaka/n02a opioider.htm/(last accessed on 20 March 2012).
21. Danish Medicine Prices. http://www.medicinpriser.dk/ (last accessed on 20 March 2012).
22. Mamdani M, Ching A, Golden B, Melo M, Menzefricke U. Challenges to evidence-based prescribing in clinical practice. Ann Pharmacother 2008;42:704-7.
23. Chan BK, Tam LK, Wat CY, Chung YF, Tsui SL, Cheung CW. Opioids in chronic non-cancer patients. Expert Opin Pharmacother 2011;12:705-20.
24. Danish National Registry of Medicinal Products Statistics. http://www.medstat.dk/ (last accessed on 20 March 2012).
25. Hamunen K, Paaklari P, Kalso E. Trends in opioid consumption in the Nordic countries 2002-2006. Eur J Pain 2009;13:954-62.
26. Bandieri E, Chiarolanza A, Luppi M, Magrini N, Marata AM, Ripamonti C. Prescription of opioids in Italy: everything, but the morphine. Ann Oncol 2009;20:961-2.
27. Ponizovsky AM, Marom E, Zeldin A, Cherny NI. Trends in opioid analgesics consumption, Israel, 2000-2008. Eur J Clin Pharmacol 2011;67:165-8.
28. Leong M, Murnion B, Haber PS. Examination of opioid prescribing in Australia from 1992 to 2007. Int Med J 2009;39:676-81.
29. Jones MI, Greenfield SM, Bradley CP. Prescribing new drugs: qualitative study of influence on consultants and general practitioners. BMJ 2001;323:378-81.
30. Fredheim OM, Skurtveit S, Breivik H, Borchgrevink PC. Increasing use of opioids from 2004 to 2007. J Pain 2010; 14:289-94.
31. Garcia del PJ, Carvajal A, Viloria JM, Velasco A, Garcia DP. Trends in the consumption of opioid analgesics in Spain. Higher increases as fentanyl replaces morphine. Eur J Clin Pharmacol 2008;64:411-5.
32. Armstrong D, Reyburn H, Jones R. A study of general practitioners' reason for changing their prescribing behaviour. BMJ 1996;312:949-52.
33. Florentinus SR, Heerdink ER, van Dijk L, Griens AM, Groenewegen PP, Leufkens HG. Is new drug prescribing in primary care specialist induced? BMC Health Serv Res 2009;9:6.
34. Grimmsmann T, Schwabe U, Himmel W. The influence of hospitalisation on drug prescription in primary care- a large scale follow-up study. Eur J Clin Pharmacol 2007;63:783-90.
35. Jacoby A, Smith M, Eccles M. A qualitative study to explore influences on general practitioners' decision to prescribe new drugs. Br J Gen Pract 2003;53:120-5.
36. Kildemoes HW, Soerensen HT, Hallas J. The Danish national prescription registry. Scand J Public Health 2011;39:38-41.
37. World Health Organization. http://www.whocc.no/atc_ddd_index/ (11 July 2012).
38. Volkow ND, McLellan TA, Cotto JH, Karithanom M, Weiss SR. Characteristics of opioid prescriptions in 2009. JAMA 2011; 305:1299-301.
39. Jarlbaek L, Kehlet H, Sjøgren P. The licit opioid consumption in Denmark [article in Danish]. Ugeskr Laeger 2010;172:3173-8.
40. Jarlbaek L, Andersen M, Kragstrup J, Hallas J. Cancer patients' share in a population's use of opioids. A linkage study between a prescription database and the Danish Cancer Registry. J Pain Symptom Manage 2004;27:36-43.
41. Victor TW, Alvarez NA, Gould E. Opioid prescribing practices in chronic pain management: guidelines does not sufficiently influence clinical practice. J Pain 2009;10:1051-7.